Cargando…
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692290/ https://www.ncbi.nlm.nih.gov/pubmed/37389847 http://dx.doi.org/10.1182/bloodadvances.2023010653 |
| _version_ | 1785152911548874752 |
|---|---|
| author | Strati, Paolo Jallouk, Andrew Deng, Qing Li, Xubin Feng, Lei Sun, Ryan Adkins, Sherry Johncy, Swapna Cain, Taylor Steiner, Raphael E. Ahmed, Sairah Chihara, Dai Fayad, Luis E. Iyer, Swaminathan P. Horowitz, Sandra Nastoupil, Loretta J. Nair, Ranjit Hassan, Ahmed Daoud, Taher E. Hawkins, Misha Rodriguez, Maria A. Shpall, Elizabeth J. Ramdial, Jeremy L. Kebriaei, Partow Hong, David S. Westin, Jason R. Neelapu, Sattva S. Green, Michael R. |
| author_facet | Strati, Paolo Jallouk, Andrew Deng, Qing Li, Xubin Feng, Lei Sun, Ryan Adkins, Sherry Johncy, Swapna Cain, Taylor Steiner, Raphael E. Ahmed, Sairah Chihara, Dai Fayad, Luis E. Iyer, Swaminathan P. Horowitz, Sandra Nastoupil, Loretta J. Nair, Ranjit Hassan, Ahmed Daoud, Taher E. Hawkins, Misha Rodriguez, Maria A. Shpall, Elizabeth J. Ramdial, Jeremy L. Kebriaei, Partow Hong, David S. Westin, Jason R. Neelapu, Sattva S. Green, Michael R. |
| author_sort | Strati, Paolo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10692290 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106922902023-12-03 A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma Strati, Paolo Jallouk, Andrew Deng, Qing Li, Xubin Feng, Lei Sun, Ryan Adkins, Sherry Johncy, Swapna Cain, Taylor Steiner, Raphael E. Ahmed, Sairah Chihara, Dai Fayad, Luis E. Iyer, Swaminathan P. Horowitz, Sandra Nastoupil, Loretta J. Nair, Ranjit Hassan, Ahmed Daoud, Taher E. Hawkins, Misha Rodriguez, Maria A. Shpall, Elizabeth J. Ramdial, Jeremy L. Kebriaei, Partow Hong, David S. Westin, Jason R. Neelapu, Sattva S. Green, Michael R. Blood Adv Research Letter The American Society of Hematology 2023-07-04 /pmc/articles/PMC10692290/ /pubmed/37389847 http://dx.doi.org/10.1182/bloodadvances.2023010653 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Strati, Paolo Jallouk, Andrew Deng, Qing Li, Xubin Feng, Lei Sun, Ryan Adkins, Sherry Johncy, Swapna Cain, Taylor Steiner, Raphael E. Ahmed, Sairah Chihara, Dai Fayad, Luis E. Iyer, Swaminathan P. Horowitz, Sandra Nastoupil, Loretta J. Nair, Ranjit Hassan, Ahmed Daoud, Taher E. Hawkins, Misha Rodriguez, Maria A. Shpall, Elizabeth J. Ramdial, Jeremy L. Kebriaei, Partow Hong, David S. Westin, Jason R. Neelapu, Sattva S. Green, Michael R. A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma |
| title | A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma |
| title_full | A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma |
| title_fullStr | A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma |
| title_full_unstemmed | A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma |
| title_short | A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma |
| title_sort | phase 1 study of prophylactic anakinra to mitigate icans in patients with large b-cell lymphoma |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692290/ https://www.ncbi.nlm.nih.gov/pubmed/37389847 http://dx.doi.org/10.1182/bloodadvances.2023010653 |
| work_keys_str_mv | AT stratipaolo aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT jalloukandrew aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT dengqing aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT lixubin aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT fenglei aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT sunryan aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT adkinssherry aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT johncyswapna aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT caintaylor aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT steinerraphaele aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT ahmedsairah aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT chiharadai aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT fayadluise aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT iyerswaminathanp aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT horowitzsandra aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT nastoupillorettaj aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT nairranjit aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT hassanahmed aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT daoudtahere aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT hawkinsmisha aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT rodriguezmariaa aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT shpallelizabethj aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT ramdialjeremyl aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT kebriaeipartow aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT hongdavids aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT westinjasonr aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT neelapusattvas aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT greenmichaelr aphase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT stratipaolo phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT jalloukandrew phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT dengqing phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT lixubin phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT fenglei phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT sunryan phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT adkinssherry phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT johncyswapna phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT caintaylor phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT steinerraphaele phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT ahmedsairah phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT chiharadai phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT fayadluise phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT iyerswaminathanp phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT horowitzsandra phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT nastoupillorettaj phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT nairranjit phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT hassanahmed phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT daoudtahere phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT hawkinsmisha phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT rodriguezmariaa phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT shpallelizabethj phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT ramdialjeremyl phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT kebriaeipartow phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT hongdavids phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT westinjasonr phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT neelapusattvas phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma AT greenmichaelr phase1studyofprophylacticanakinratomitigateicansinpatientswithlargebcelllymphoma |